PMA supplement

P900033 S022: INTEGRA DERMAL REGENERATION TEMPLATE

FDA PMA supplement · 30-Day Notice · Integra Lifesciences Corp.

Key facts

Original PMA P900033
Supplement number S022
Supplement type 30-Day Notice
Trade name INTEGRA DERMAL REGENERATION TEMPLATE
Generic name Device, dermal replacement
Applicant Integra Lifesciences Corp.
Product code MDD
Received date Jul 23, 2012
Decision date Aug 22, 2012

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements